cisplatin

You have access
High Expression of p21 as a Potential Therapeutic Target in Ovarian Clear-cell Carcinoma
YUKI MINAGAWA, KOUSUKE ISHINO, RYUICHI WADA, MITSUHIRO KUDO, ZENYA NAITO, TOSHIYUKI TAKESHITA and RYUJI OHASHI

Anticancer Research October 2020, 40 (10) 5631-5639; DOI: https://doi.org/10.21873/anticanres.14576
You have access
Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX
JEAN-DAVID FUMET, JULIE VINCENT, LEILA BENGRINE, AUDREY HENNEQUIN, LAURA GRANCONATO, REMI PALMIER and FRANÇOIS GHIRINGHELLI

Anticancer Research July 2020, 40 (7) 4011-4015; DOI: https://doi.org/10.21873/anticanres.14395
You have access
Characteristics of Gastric Carcinomas With High ERCC1 Expression and the Prognostic Value of ERCC1 Expression
JUNG WOOK YANG, JEONG-HEE LEE, JONG SIL LEE, DONG CHUL KIM, DAE HYUN SONG, SE MIN JANG, HYO JUNG AN, HYUN MIN KOH, MINHYE KIM, JI MIN NA, SANG-HO JEONG, YOUNG-JOON LEE and GYUNG HYUCK KO

Anticancer Research June 2020, 40 (6) 3203-3208; DOI: https://doi.org/10.21873/anticanres.14301
You have access
Clinical Significance of Jagged-1 Activated by APEX1 as a Chemoresistance Factor in Advanced Gastric Cancer
HONG-BEUM KIM, HEE-JEONG LEE, GEE-BEUM KIM, HYUN-JONG LIM, JUN HEE PARK and SANG-GON PARK

Anticancer Research April 2020, 40 (4) 1897-1904; DOI: https://doi.org/10.21873/anticanres.14144
You have access
Cigarette Smoke Reduces the Efficacy of Cisplatin in Head and Neck Cancer Cells – Role of ABCG2
FLORIAN SIMON, SABINA SCHWENK-ZIEGER, SVEN BECKER, KRISTIAN UNGER, OLIVIER GIRES and PHILIPP BAUMEISTER

Anticancer Research March 2020, 40 (3) 1277-1284; DOI: https://doi.org/10.21873/anticanres.14069
You have access
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Ovarian Cancer: Evaluation of Side Effects in a Single Institution Cohort
MICHAEL FRIEDRICH, WOLFGANG ZINN, LAURA KOLNSBERG, CLAYTON KRAFT and WALTHER KUHN

Anticancer Research March 2020, 40 (3) 1481-1486; DOI: https://doi.org/10.21873/anticanres.14092
You have access
Phase II Study of Second-line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma
MASAHIRO OGAWA, SHINYA YAMAMOTO, TORU INOUE, NOBORU NUMAO, TAKESHI YUASA, HITOSHI MASUDA, IWAO FUKUI and JUNJI YONESE

Anticancer Research March 2020, 40 (3) 1613-1618; DOI: https://doi.org/10.21873/anticanres.14109
You have access
Non-steroidal Anti-inflammatory Drugs Are a Risk Factor for Cisplatin-induced Nephrotoxicity: A Meta-analysis of Retrospective Studies
KEISUKE OKAMOTO, YOSHITAKA SAITO, KATSUYA NARUMI, AYAKO FURUGEN, KEN ISEKI and MASAKI KOBAYASHI

Anticancer Research March 2020, 40 (3) 1747-1751; DOI: https://doi.org/10.21873/anticanres.14128
You have access
Chronic Stimulation of the Autophagy-inducing Ingredient of Areca Nut Promotes Tumor Growth In Vivo Through Up-regulation of Tumoral Autophagy
CHANG-TA CHIU, SHYUN-YEU LIU, CHING-YU YEN, BANG-YEN LIU, ZI-YU SUN, CHUN-YI WU, JI-LUNG DENG, YOUNG-CHAU LIU and MEI-HUEI LIN

Anticancer Research January 2020, 40 (1) 221-227; DOI: https://doi.org/10.21873/anticanres.13943
You have access
Cisplatin Induced the Expression of SEI1 (TRIP-Br1) Oncogene in Human Oral Squamous Cancer Cell Lines
JUNAN LI, ZACHARY VANGUNDY and MING POI

Anticancer Research January 2020, 40 (1) 67-73; DOI: https://doi.org/10.21873/anticanres.13926

Main menu

User menu

Search

cisplatin

Pages